These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 404854)

  • 21. Purine nucleoside phosphorylase deficiency. Measurement of variant protein in four families with enzyme-deficient members by an enzyme-linked immunosorbent assay.
    Osborne WR; Scott CR
    Am J Hum Genet; 1980 Nov; 32(6):927-33. PubMed ID: 6778206
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Purine nucleoside phosphorylase deficiency associated with selective cellular immunodeficiency.
    Stoop JW; Zegers BJ; Hendrickx GF; van Heukelom LH; Staal GE; de Bree PK; Wadman SK; Ballieux RE
    N Engl J Med; 1977 Mar; 296(12):651-5. PubMed ID: 402573
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Abnormal purine metabolism and purine overproduction in a patient deficient in purine nucleoside phosphorylase.
    Cohen A; Doyle D; Martin DW; Ammann AJ
    N Engl J Med; 1976 Dec; 295(26):1449-54. PubMed ID: 825775
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nucleotide metabolism in cultured T cells and in cells of patients deficient in adenosine deaminase and purine nucleoside phosphorylase.
    Cohen A; Gudas LJ; Ullman B; Martin DW
    Ciba Found Symp; 1978; (68):101-14. PubMed ID: 115659
    [No Abstract]   [Full Text] [Related]  

  • 25. Enzyme defects in purine metabolism and immunodeficiencies.
    Ito K
    Nihon Ketsueki Gakkai Zasshi; 1985 Dec; 48(8):1764-71. PubMed ID: 3939170
    [No Abstract]   [Full Text] [Related]  

  • 26. High risk screening of adenosine deaminase and purine nucleoside phosphorylase deficiency in Japan.
    Kishi T; Sakura N; Ito K; Usui T
    Acta Paediatr Jpn; 1987 Feb; 29(1):152-4. PubMed ID: 3144840
    [No Abstract]   [Full Text] [Related]  

  • 27. Immunological aberrations in purine nucleoside phosphorylase deficiencies.
    Ammann AJ
    Ciba Found Symp; 1978; (68):55-75. PubMed ID: 159164
    [No Abstract]   [Full Text] [Related]  

  • 28. Inherited enzyme deficiencies and immunodeficiency: adenosine deaminase (ADA) and purine nucleoside phosphorylase (PNP) deficiencies.
    Hirschhorn R
    Clin Immunol Immunopathol; 1986 Jul; 40(1):157-65. PubMed ID: 3087666
    [No Abstract]   [Full Text] [Related]  

  • 29. Cellular immune deficiency with autoimmune hemolytic anemia in purine nucleoside phosphorylase deficiency.
    Rich KC; Arnold WJ; Palella T; Fox IH
    Am J Med; 1979 Jul; 67(1):172-6. PubMed ID: 111549
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immune cell function and recycling of purines.
    Giblett ER
    N Engl J Med; 1976 Dec; 295(24):1375-6. PubMed ID: 824556
    [No Abstract]   [Full Text] [Related]  

  • 31. Inosine formation from hypoxanthine by intact erythrocytes and fibroblasts of an immunodeficient child with purine nucleoside phosphorylase deficiency.
    Fairbanks LD; Webster DR; Simmonds HA; Potter CF; Watson AR
    Adv Exp Med Biol; 1984; 165 Pt B():167-70. PubMed ID: 6426263
    [No Abstract]   [Full Text] [Related]  

  • 32. Red cell metabolism in purine nucleoside phosphorylase deficiency after enzyme replacement therapy.
    Staal GE; Stoop JW; Zegers BJ; van der Vlist MJ; de Bruyn CH; Wadman SK
    Monogr Hum Genet; 1978; 10():104-7. PubMed ID: 102921
    [No Abstract]   [Full Text] [Related]  

  • 33. Deoxyguanosine triphosphate as a possible toxic metabolite in the immunodeficiency associated with purine nucleoside phosphorylase deficiency.
    Cohen A; Gudas LJ; Ammann AJ; Staal GE; Martin DW
    J Clin Invest; 1978 May; 61(5):1405-9. PubMed ID: 96138
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combined familial adenosine deaminase and purine nucleoside phosphorylase deficiencies.
    Shanon A; Levin S; Holtzman F; Brock-Sinai F; Abu-Said A
    Arch Dis Child; 1988 Aug; 63(8):931-4. PubMed ID: 3137899
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of a cell culture model for the study of adenosine deaminase- and purine nucleoside phosphorylase-deficient immunologic disease.
    Ullman B; Cohen A; Martin DW
    Cell; 1976 Oct; 9(2):205-11. PubMed ID: 184961
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Purine nucleoside phosphorylase deficiency: improved metabolic and immunologic function with erythrocyte transfusions.
    Rich KC; Majias E; Fox IH
    N Engl J Med; 1980 Oct; 303(17):973-7. PubMed ID: 6774252
    [No Abstract]   [Full Text] [Related]  

  • 37. [Adenosine deaminase and nucleoside phosphorylase: a new approach to the etiopathogenesis of various immunologic deficiencies].
    Lucivero G; Dammacco F; Bonomo L
    Recenti Prog Med; 1977 Sep; 63(3):275-88. PubMed ID: 413174
    [No Abstract]   [Full Text] [Related]  

  • 38. Proposed explanation for S-adenosylhomocysteine hydrolase deficiency in purine nucleoside phosphorylase and hypoxanthine-guanine phosphoribosyltransferase-deficient patients.
    Hershfield MS
    J Clin Invest; 1981 Mar; 67(3):696-701. PubMed ID: 6782120
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A new form of nucleoside phosphorylase deficiency in two brothers with defective T-cell function.
    Biggar WD; Giblett ER; Ozere RL; Grover BD
    J Pediatr; 1978 Mar; 92(3):354-7. PubMed ID: 416186
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Deoxyribonucleoside toxicity in adenosine deaminase and purine nucleoside phosphorylase deficiency: implications for the development of new immunosuppressive agents.
    Carson DA; Kaye J
    Ciba Found Symp; 1978; (68):115-33. PubMed ID: 115660
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.